Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial (Q72887990)
Jump to navigation
Jump to search
scientific article published on 01 September 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial |
scientific article published on 01 September 1993 |
Statements
Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial (English)
G I Barbash
M Modan
F Van de Werf
1 September 1993